CClinicalTrials.gg
Not yet recruitingNCT07369843LASERBFUpdated Jan 27, 2026

LASER Effects Blood Flow

An interventional study of physical therapy (low power LASER) in Pain Management, sponsored by Saint Paul's Hospital, Congregation Of The Sisters Of Saint Paul De Chartres. Not yet recruiting. Open to participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-27.

Sponsored by Saint Paul's Hospital, Congregation Of The Sisters Of Saint Paul De Chartres · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Not applicable
Ages
20 Years to 45 Years
Sex
All
01

Study summary

This study investigate the potential impact of low power laser (LPL), an non-invasive physical therapy, on the cardiovascular system by focusing on its effect on heart rate and autonomic tone.

Study will recruit healthy volunteers and non-invasively monitor their electrocardiogram and digital pulse in response to LPL.

In addition, the potential involvement of autonomic tone will be clarify by topically applying gel (2% lidocaine gel)

Read the detailed description

This study investigate the potential impact of low power laser (LPL), an non-invasive physical therapy, on the cardiovascular system by focusing on its effect on heart rate and autonomic tone.

Study will recruit healthy volunteers (age 20-60; having no diabetes, hypertension, or other medical problem) and non-invasively monitor their electrocardiogram and digital pulse in response to LPL (with an intensity for relieving pain).

In addition, the potential involvement of autonomic tone will be clarify by topically applying gel (2% lidocaine gel) at the site 2 cm distal to the applying site.

02

Conditions studied

  • Pain Management

Browse trials for

Keywords

  • low power LASER
  • Heart rate
  • autonomic tone
03

In context

Agnosia

1,190 studies on the registry are indexed under Agnosia; 508 are open to participants now.

This study's planned enrollment of 45 is below the median of 78 across 1,024 interventional studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

This is the only study on the registry with Saint Paul's Hospital, Congregation Of The Sisters Of Saint Paul De Chartres as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age from 20-45

Exclusion criteria

Exclusion Criteria:

  • no medical history of diabetes, hypertension, or other medical problem
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    test effect

    Control, experiment, and recovery data will be acquired for each volunteer

    Other: physical therapy (low power LASER)

Interventions

  • Otherphysical therapy (low power LASER)

    Low power laser with an intensity for pain relieving will be applied to volunteers

06

What researchers measure

Primary outcomes

  1. heart rate

    the heart rate before, during, and after low power LASER

    Time frame: Continuous heart rate (HR) recording will start when it is stable after a brief resting (10 min); maintained during stimulation (30 min), and lasted for a period until the HR recovers.

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07369843
Lead sponsor
Saint Paul's Hospital, Congregation Of The Sisters Of Saint Paul De Chartres
Responsible party
Sponsor
First posted
Jan 27, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
May 30, 2026 (estimated)
Completion
May 30, 2026 (estimated)
Last update
Jan 27, 2026

Study contacts

Chun-Ming Hsieh, MS
Contact
tblin2@gmail.com
+886-(03)361-3141 ext. 8714
Tzer-Bin Lin, Ph.D.
Contact
+886-0935-972505

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion